Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	78.28	50.87	2.48	4.06	19.77	9.8
Short-Term Investments	-	-	-	-	-	0
Cash & Short-Term Investments	78.28	50.87	2.48	4.06	19.77	9.8
Cash Growth	284.23%	1953.53%	-39.02%	-79.45%	101.68%	-37.64%
Accounts Receivable	-	0.23	0.06	0	0.03	0.06
Other Receivables	0	-	-	-	-	-
Receivables	0	0.23	0.06	0	0.03	0.06
Prepaid Expenses	0.37	0.52	1.18	0.74	0.8	0.86
Restricted Cash	0.06	0.06	0.01	0.01	0.02	-
Other Current Assets	-	-	-	-	-	0.09
Total Current Assets	78.71	51.67	3.73	4.82	20.61	10.81
Property, Plant & Equipment	0.29	0.45	0.61	0.99	0.58	0.77
Other Long-Term Assets	0.07	0.09	0.12	0.16	0.19	0.01
Total Assets	79.07	52.21	4.46	5.97	21.38	11.59
Accounts Payable	0.59	1.35	1.14	0.42	0.27	0.28
Accrued Expenses	0.67	0.65	0.74	0.7	0.49	0.46
Current Portion of Leases	0.14	0.28	0.28	0.25	0.21	0.19
Other Current Liabilities	1.69	2.64	1.82	1.16	0.39	0.2
Total Current Liabilities	3.09	4.92	3.98	2.53	1.37	1.14
Long-Term Leases	-	-	0.28	0.56	-	0.21
Total Liabilities	3.13	4.96	4.26	3.09	1.37	1.35
Common Stock	0	0	-	-	0	-
Additional Paid-In Capital	279.3	238.4	168.92	152.45	151.58	128.83
Retained Earnings	-202.68	-190.26	-167.89	-148.33	-130.12	-116.64
Comprehensive Income & Other	-0.69	-0.89	-0.83	-1.25	-1.46	-1.95
Shareholders' Equity	75.94	47.25	0.2	2.88	20.01	10.24
Total Liabilities & Equity	79.07	52.21	4.46	5.97	21.38	11.59
Total Debt	0.14	0.28	0.56	0.81	0.21	0.41
Net Cash (Debt)	78.15	50.58	1.92	3.25	19.56	9.4
Net Cash Growth	291.69%	2537.23%	-41.00%	-83.38%	108.11%	-40.22%
Net Cash Per Share	7.07	12.46	1.38	6.76	77.40	156.43
Filing Date Shares Outstanding	23.45	10.56	2.55	0.48	0.48	0.07
Total Common Shares Outstanding	23.45	10.09	1.65	0.48	0.48	0.07
Working Capital	75.62	46.75	-0.25	2.29	19.24	9.67
Book Value Per Share	3.24	4.68	0.12	6.00	41.63	157.03
Tangible Book Value	75.94	47.25	0.2	2.88	20.01	10.24
Tangible Book Value Per Share	3.24	4.68	0.12	6.00	41.63	157.03
Machinery	1.57	1.55	1.38	1.37	1.36	1.14
Leasehold Improvements	0.02	0.02	0.02	0.02	0.02	0.02

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q